Immune-related adverse events of checkpoint inhibitors
…, X Mariette, A Prat, ME Suárez-Almazor - Nature reviews Disease …, 2020 - nature.com
Cancer immunotherapies have changed the landscape of cancer treatment during the past
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
few decades. Among them, immune checkpoint inhibitors, which target PD-1, PD-L1 and …
International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001
…, AM Prieur, ME Suarez-Almazor… - The Journal of …, 2004 - pubmed.ncbi.nlm.nih.gov
International League of Associations for Rheumatology classification of juvenile idiopathic
arthritis: second revision, Edmonton, 2001 International League of Associations for …
arthritis: second revision, Edmonton, 2001 International League of Associations for …
Management of immune-related adverse events in patients treated with immune checkpoint inhibitor therapy: American Society of Clinical Oncology Clinical Practice …
…, A Spira, ME Suarez-Almazor, Y Wang… - Journal of clinical …, 2018 - ascopubs.org
Purpose To increase awareness, outline strategies, and offer guidance on the recommended
management of immune-related adverse events in patients treated with immune …
management of immune-related adverse events in patients treated with immune …
Occurrence, causes, and outcome of delirium in patients with advanced cancer: a prospective study
…, J Hanson, ME Suarez-Almazor… - Archives of internal …, 2000 - jamanetwork.com
Context Delirium impedes communication and contributes to symptom distress in patients
with advanced cancer. There are few prospective data on the reversal of delirium in this …
with advanced cancer. There are few prospective data on the reversal of delirium in this …
Racial and ethnic disparities in the use of health services: bias, preferences, or poor communication?
…, LA Petersen, BF Sharf, ME Suarez-Almazor… - Journal of general …, 2003 - Springer
African Americans and Latinos use services that require a doctor’s order at lower rates than
do whites. Racial bias and patient preferences contribute to disparities, but their effects …
do whites. Racial bias and patient preferences contribute to disparities, but their effects …
Biologics for rheumatoid arthritis: an overview of Cochrane reviews
…, GA Wells, ME Suarez‐Almazor… - Cochrane Database …, 2009 - cochranelibrary.com
Background The biologic disease‐modifying anti‐rheumatic drugs (DMARDs) are very
effective in treating rheumatoid arthritis (RA), however there is a lack of head‐to‐head …
effective in treating rheumatoid arthritis (RA), however there is a lack of head‐to‐head …
Health related quality of life outcomes after total hip and knee arthroplasties in a community based population.
…, DW Johnston, ME Suarez-Almazor - The Journal of …, 2000 - europepmc.org
Objective To quantify the magnitude of change seen with pain, function, and quality of life
outcomes 6 months after total hip and knee arthroplasties (THA, TKA) within a community …
outcomes 6 months after total hip and knee arthroplasties (THA, TKA) within a community …
The effect of age on pain, function, and quality of life after total hip and knee arthroplasty
…, DWC Johnston, ME Suarez-Almazor - Archives of internal …, 2001 - jamanetwork.com
Background As utilization rates for total joint arthroplasty increase, there is a hesitancy to
perform this surgery on very old patients. The objective of this prospective study was to …
perform this surgery on very old patients. The objective of this prospective study was to …
Total joint arthroplasties: current concepts of patient outcomes after surgery
…, DWC Johnston, ME Suarez-Almazor - … Disease Clinics of North …, 2007 - Elsevier
Total hip and knee arthroplasties are effective surgical interventions for relieving hip pain
and improving physical function caused by arthritis. Although the majority of patients …
and improving physical function caused by arthritis. Although the majority of patients …
Adverse events associated with immune checkpoint blockade in patients with cancer: a systematic review of case reports
N Abdel-Wahab, M Shah, ME Suarez-Almazor - PloS one, 2016 - journals.plos.org
Background Three checkpoint inhibitor drugs have been approved by the US Food and Drug
Administration for use in specific types of cancers. While the results are promising, severe …
Administration for use in specific types of cancers. While the results are promising, severe …